George Kottayil - Dec 19, 2023 Form 4 Insider Report for Acasti Pharma Inc. (ACST)

Role: Director
Signature: /s/ George Kottayil
Stock symbol: ACST
Transactions as of: Dec 19, 2023
Transactions value $: $0
Form type: 4
Date filed: 12/20/2023, 04:08 PM
Previous filing: Oct 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ACST	Stock Options (Right to Buy)	Award	$0	+22.5K		$0.00	22.5K	Dec 19, 2023	Class A Common Shares	22.5K	$2.13	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Stock options granted on 12/19/2023 under the Acasti Pharma Stock Option Plan, which 10,000 shares vest in equal monthly installments over a period of 12 months (provided that 3/12 of the options shall be deemed to have vested upon the date of grant), and 12,500 shares vest in equal quarterly installments over a period of 18 months (Provided that 1/6 of the options shall be deemed to have vested upon the date of grant).

Content

Stock options granted on 12/19/2023 under the Acasti Pharma Stock Option Plan, which 10,000 shares vest in equal monthly installments over a period of 12 months (provided that 3/12 of the options shall be deemed to have vested upon the date of grant), and 12,500 shares vest in equal quarterly installments over a period of 18 months (Provided that 1/6 of the options shall be deemed to have vested upon the date of grant).